Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1998 Dec 7;11(1):39–44. doi: 10.1002/(SICI)1098-2825(1997)11:1<39::AID-JCLA7>3.0.CO;2-F

Serum protein standardization project in Japan: Evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals

Yoshihisa Itoh 1,, Kiyoshi Ichihara 2, Takashi Kanno 3, Takao Sugawara 4, Akiyuki Ohkubo 5, Youji Hirabayashi 6, Sumiko Igarashi 7, Kinnya Kawano 8, Susumu Iwata 9, Kensuke Saito 10, Tadashi Kawai 1
PMCID: PMC6703103  PMID: 9021523

Abstract

Reference preparation for proteins in human serum (RPPHS), also called Certified Reference Material 470 (CRM 470), was prepared by the International Federation of Clinical Chemistry (IFCC) and is intended to serve as a new international plasma protein reference material. It is now being introduced into Japan. RPPHS possesses many excellent properties, including safety, stability, and accuracy in value assignment. Moreover, the physicochemical properties of its proteins are identical to those of fresh serum, giving it immunochemical behavior that is commutable with that of existing reference materials and calibrators in given immunoassays. Reference intervals of 13 serum proteins were determined for the first time using nephelometry and a new working calibrator assigned from RPPHS, which seems certain to play a critical role in the global standardization of specific protein immunoassays. J. Clin. Lab. Anal. 11:39–44. © 1997 Wiley‐Liss, Inc.

Keywords: C‐reactive protein, RPPHS/CRM470, stability, standardization, safety, reference intervals, quality assurance

References

  • 1. Baudner S: Measurement signal versus value in immunoassays for human plasma proteins. Scand J Lab Invest 51(suppl. 205): 70–78, 1991. [DOI] [PubMed] [Google Scholar]
  • 2. Baudner S: Modern aspects and requirements for the standardization of immunoassays for human plasma proteins. J Clin Lab Analysis 7: 273–277, 1993. [DOI] [PubMed] [Google Scholar]
  • 3. Baudner S: Why a new reference preparation (IRP) for human plasma proteins. J Clin Lab Analysis 7: 273–277, 1993. [DOI] [PubMed] [Google Scholar]
  • 4. Whicher JT, Richie RF, Johnson M, Baudner S, Bienvenu J, Blirup‐Jensen S, Carlström A, Dati F, Ward AM, Svendsen PJ: New international reference preparation for proteins in human serum (RPPHS). Clin Chem 40: 934–938, 1994. [PubMed] [Google Scholar]
  • 5. Johnson AM: A new international preparation for proteins in human serum. Arch Pathol Lab Med 117: 29–31, 1993. [PubMed] [Google Scholar]
  • 6. Itoh Y, Kawano K, Iwata S, Kanno T, Ichihara K, Ohkubo A, Sugawara T, Igarahi S, Hirabayashi Y, Saito N, Kawai T: Evaluation of a new international reference material for plasma proteins: CRM470—its safety, stability, and assigned value. J Lab Instruments Reagents (in Japanese) 18: 1–12, 1995. [Google Scholar]
  • 7. Baudner S, Bienvenu J, Bilrup‐Jensen S, Carlström A, Johnson AM, Milford‐Ward A, Whicher JT: The Certification of a Matrix Reference Material for Immunochemical Measurement of 14 Human Serum Proteins. CRM 470. Brussels: Community of Bureau of Reference, Commission of the European Communities, 1993, p 1–172.
  • 8. Nakagiri I, Ichihara K: ELISA for anti‐HCV antibody employing a shorter synthetic core region peptide. J Virol Meth 52: 195–207, 1995. [DOI] [PubMed] [Google Scholar]
  • 9. Ichihara K, Kawai T. Determination of reference intervals for 13 plasma proteins based on CRM470 standards and NCCLS‐proposed guideline (C28‐P, 1992): (1) A trial to select reference individuals by results of screening tests and application of the maximal likelihood method. J Clin Lab Analysis 10: 110–117, 1995. [DOI] [PubMed] [Google Scholar]
  • 10. Kawai T: Reference intervals in the clinical laboratory In: Quality Control in the Clinical Laboratory 1995: Toward a New QC‐QA‐QM Paradigm. Excepta Medica, Tokyo, 1995, p 17–23. [Google Scholar]
  • 11. Ichihara K, Kawai T. Determination of reference intervals for 13 plasma proteins based on CRM470 standards and NCCLS‐proposed guideline (C28‐p, 1992): (2) A strategy for partitioning a reference sample with validation multivariate analysis. J Clin Lab Analysis 1996. (in press). [DOI] [PMC free article] [PubMed]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES